Clinical trials
Diabetes Mellitus, Type 2 trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
258 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 9 |
| 2004 | 4 |
| 2005 | 15 |
| 2006 | 18 |
| 2007 | 12 |
| 2008 | 13 |
| 2009 | 13 |
| 2010 | 32 |
| 2011 | 6 |
| 2012 | 13 |
| 2013 | 14 |
| 2014 | 14 |
| 2015 | 9 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 10 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 196 |
| Terminated | 26 |
| Recruiting | 16 |
| Active, not recruiting | 7 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 32 |
| AstraZeneca | 31 |
| Eli Lilly and Company | 24 |
| Hoffmann-La Roche | 17 |
| Boehringer Ingelheim | 16 |
| Sanofi | 14 |
| Takeda | 12 |
| GlaxoSmithKline | 9 |
| Janssen Research & Development, LLC | 7 |
| Bayside Health | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 258 |
| Diabetes Mellitus | 58 |
| Obesity | 27 |
| Cardiovascular Diseases | 13 |
| Glucose Metabolism Disorders | 11 |
| Diabetic Nephropathies | 10 |
| Insulin Resistance | 10 |
| Overweight | 10 |
| Diabetes Mellitus, Type 1 | 9 |
| Dyslipidemias | 8 |
Trials
Showing 26 to 50 of 258. Each trial links to its page on Pharma Observatory.
158 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.